Life Extension 5-LOX Inhibitor with AprèsFlex 100 mg, 60 vege caps

Item No: 001639
Availability: In Stock

S$41.10
Ex GST: S$38.41
Pricing for shipping addresses out of Singapore
10% off for 4 or more

Qty

Add to Cart

Pre Order Form

We will keep you posted on stock status.

Description
Supplement Facts

5-lipoxygenase (5-LOX) is a member of the lipoxygenase family of enzymes. It transforms fatty acids into leukotrienes. Excess levels of the enzyme 5-LOX sets in motion inflammatory responses that have been linked to common effects in aging individuals.70-74

Normal aging results in higher-than-desired levels of 5-LOX.

The typical American diet adds to the danger. Foods rich in omega-6 fatty acids like red meat, poultry, eggs and dairy products, along with high-glycemic carbohydrates, trigger overproduction of arachidonic acid. In response to high levels of arachidonic acid, the body produces the 5-LOX enzyme.

5-LOX breaks down arachidonic acid to pro-inflammatory compounds like leukotriene B4,75 a molecule that mediates attacks to joints, arterial walls, and other tissues. 5-LOX itself facilitates undesirable cell division changes.76,77

The good news is that an extract of the Indian plant Boswellia serrata has been shown to neutralize 5-LOX. Used for centuries to help with inflammatory factors, boswellia acts as a natural 5-LOX inhibitor, intervening at the cellular level to block its unwanted effects. Confirmatory data reveal that a compound contained in boswellia calledAKBA (3-O-acetyl-11-keto-ß-boswellic acid)78,79 is the key to its beneficial action.

The problem is that boswellia is poorly absorbed into the blood.80 For this reason, a patent-pending, standardized form of boswellia called AprèsFlex® is being introduced. AprèsFlex® absorbs into the blood 52% more than previously available boswellia extracts.80

Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex® is standardized to provide 20% of activeAKBA from boswellia. Most people need only one capsule a day.

Supplement Facts

Serving Size 1 vegetarian capsule
Amount Per Serving
AprèsFlex® (Boswellia serrata) extract (gum resin) [std. to 20% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) (20 mg)]	100 mg
Other ingredients: microcrystalline cellulose, vegetable cellulose (capsule), silica, vegetable stearate.

AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. U.S. Patent No. 8,551,496 and other patents pending.

Dosage and Use

To inhibit the 5-lipoxygenase enzyme, take one (1) capsule daily with or without food, or as recommended by a healthcare practitioner.

Warnings

KEEP OUT OF REACH OF CHILDREN
DO NOT EXCEED RECOMMENDED DOSE
Do not purchase if outer seal is broken or damaged.
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

References

1. Anticancer Res. 2004 Mar-Apr;24(2B):563-9.
2. Chem Soc Rev. 2008 Nov;37(11):2558-74.
3. Antioxid Redox Signal. 2008 Mar;10(3):511-45.
4. Arch Pharm (Weinheim). 2010 Sep;343(9):489-99.
5. J Ethnopharmacol. 2010 Mar 24;128(2):549-53.
6. Arch Toxicol. 2010 May;84(5):389-96.
7. Asia Journal of Applied Sciences 4 (4):343-354,2011
8. J Alzheimer’s Dis. 2004 Aug;6(4):367-7.
9. J Immunol. 2004 May 15;172(10):5940-7.
10. Integr Biol (Camb). 2012 Aug;4(8):905-13.
11. Biol Pharm Bull. 2011;34(7):974-9.
12. Chin Med. 2008 Sep 17;3:11.
13. Acta Biochim Biophys Sin (Shanghai). 2012 Oct;44(10):847-55.
14. Curr Drug Targets. 2011 Mar 1;12(3):332-47.
15. Oncol Rep. 2013 Jan;29(1):117-24.
16. Dig Dis Sci. 2005 Nov;50(11):2191-3.
17. Biochem Pharmacol. 2008 Feb 15;75(4):787-809.
18. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1502-6.
19. Inflamm Bowel Dis. 2011 Feb;17(2):503-15.
20. PLoS One. 2010 Dec 3;5(12):e15099.
21. Indian J Pharmacol. 2011 Sep;43(5):546-50.
22. Genes Nutr. 2011 May;6(2):171-9.
23. J Fam Pract. 2011 Mar;60(3):155-6.
24. Arthritis Res Ther. 2011 Feb 3;13(1):102.
25. J Endotoxin Res. 2007;13(1):15-23.
26. Prostaglandins Leukot Essent Fatty Acids. 1995 Apr;52(4):223-7.
27. Mol Cancer Ther. 2006 May;5(5):1371-82.
28. Platelets. 2011;22(4):270-6.
29. Mol Nutr Food Res. 2008 Sep;52(9):1031-9.
30. Arch Med Res. 2011 Feb;42(2):79-87.
31. J Ethnopharmacol. 2011 Jul 14;136(3):414-21
32. Journal of Neuroscience. 2001;21(21):8370–8377.
33. Journal of Biological Chemistry. 2005;280(7):5892–5901.; discussion 606-7.
34. Cellular and Molecular Life Sciences. 2006;63(13):1538–1552.
35. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S189-94.
36. J Neurochem. 2010 Mar;112(6):1415-30.
37. Biochem Biophys Res Commun. 2010 Feb 19;392(4):567-71.
38. PLoS One. 2010 Jan 8;5(1):e8643.
39. Curr Drug Targets. 2011 Mar 1;12(3):332-47.
40. Indian J Pharm Sci. 2010 Mar;72(2):149-54.
41. Neuroscience. 2010 Sep 1;169(3):1296-306.
42. Eur J Pharmacol. 2007 Dec 22;577(1-3):183-91.
43. Br J Pharmacol. 2008 Nov;155(5):702-13.
44. Free Radic Res. 2011 Jul;45(7):788-95.
45. Nutr Metab (Lond). 2011 Jun 10;8(1):35.
46. Mol Nutr Food Res. 2011 Nov;55(11):1655-65.
47. Diabetes. 2011 Nov;60(11):2928-38.
48. Zhonghua Yi Xue Za Zhi. 2003 Oct 25;83(20):1764-8.
49. Biochem Biophys Res Commun. 1997 Apr 28;233(3):692-6.
50. Endocrinology. 2012 Feb;153(2):554-63.
51. Int J Oncol. 2012 Feb;40(2):436-42
52. Evid Based Complement Alternat Med. 2012;2012:486568.
53. Curr Alzheimer Res. 2007 Apr;4(2):117-22.
54. JAMA. 2004 Feb 11;291(6):704-10.
55. Nutr Rev. 2007 Dec;65(12 Pt 2):S173-6.
56. Biol Psychiatry. 2003 Sep 1;54(5):566-72.
57. Immunol Allergy Clin North Am. 2003 Feb;23(1):15-39.
58. Cancer Ther. 2008;6(b):495-510.
59. Int Immunopharmacol. 2005 Dec;5(13-14):1749-70.
60. J Ethnopharmacol. 2011 Sep 2;137(2):1028-34.
61. Am J Chin Med. 2011;39(6):1075-91.
62. Pak J Biol Sci. 2011 Dec 1;14(23):1038-46.
63. Dig Dis Sci. 2012 Sep;57(9):2296-303.
64. Phytother Res. 2007 Sep;21(9):895-7.
65. Immunol Lett. 2006 Jul 15;106(1):72-81.
66. HPB (Oxford). 2009 Aug;11(5):373-81.
67. Int J Immunopharmacol. 2000 Sep;22(9):729-40.
68. Pulm Pharmacol Ther. 2009 Feb;22(1):37-43.
69. Crit Rev Food Sci Nutr. 2010 Aug;50(7):654-65.
70. Neurobiol Aging. 2007 Sep;28(9):1457-62.
71. Cardiovasc Psychiatry Neurol. 2009;2009:174657.
72. Free Radic Biol Med. 2009 Jul 1;47(1):62-71.
73. Rejuvenation Res. 2009 Feb;12(1):15-24.
74. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):315-9.
75. Curr Opin Investig Drugs. 2009 Nov;10(11):1163-72.
76. Carcinogenesis. 2006 Sep;27(9):1902-8.
77. Clin Cancer Res. 2005 Mar 1;11(5):2089-96.
78. Wien Med Wochenschr. 2002;152(15-16):373-8.
79. J Ethnopharmacol. 2006 Sep 19;107(2):249-53.
80. Mol Cell Biochem. 2011 Aug;354(1-2):189-97.
81. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1365-70.
82. Clin Immunol. 2008 Jul;128(1):66-74.
83. Biotechnol Res Int. 2012;2012:976203. doi: 10.1155/2012/976203. Epub 2012 Dec 10.
84. Altern Ther Health Med. 2012 Sep-Oct;18(5):9-17.
85. Phytother Res. 2013 Feb;27(2):199-204.
86. J Surg Res. 2012 Aug;176(2):503-9.
87. Zhong Xi Yi Jie He Xue Bao. 2011 Jul;9(7):702-10.
88. Altern Med Rev. 2010 Dec;15(4):361-8.
89. Eur Rev Med Pharmacol Sci. 2010 Sep;14(9):771-4.
90. Clin Immunol. 2008 Mar;126(3):345-52.
91. Evid Based Complement Alternat Med. 2004 Dec;1(3):251-7.
92. Clin Exp Rheumatol. 2006 Jan-Feb;24(1):25-30.
93. Clin Rheumatol. 2004 Oct;23(5):410-5.
94. Int Immunopharmacol. 2009 Mar;9(3):313-8.
95. Clin Rheumatol. 2009 Aug;28(8):931-463.
96. Chandran B, Chakkiath VK, Thomas SPO. A multicentre, randomized, controlled human clinical study to assess the efficacy and safety of Biocurcumax (BCM-95®) compared to diclofenac sodium. Submitted for publication. 2009
97. Biomed Pharmacother. 2002 Oct;56(8):365-79.
98. Przegl Lek. 2007;64(2):91-9.
99. Prostaglandins Leukot Essent Fatty Acids. 2006 Mar;74(3):165-73.
100. Minerva Pediatr. 2008 Apr;60(2):219-33
101. JAMA. 2004 Sep 22;292(12):1440-6.
102. Int J Epidemiol. 1997 Feb;26(1):155-9.
103. Br J Nutr. 2012 Aug;108(4):699-709.
104. N Engl J Med. 2003 Jun 26;348(26):2599-608.
105. Br J Nutr. 2000 Dec;84 Suppl 2:S205-9.
106. Clin Interv Aging. 2008;3(1):97-109.
107. JAMA. 2004 Sep 22;292(12):1433-9.
108. Rejuvenation Res. 2012 Apr;15(2):184-8.
109. Am J Clin Nutr. 2000 Apr;71(4):987-92.
110. Am J Clin Nutr. 2008 Jun;87(6):1991S-6S.
111. Curr Atheroscler Rep. 2008 Dec;10(6):503-9.
112. J Nutr. 2010 May;140(5):1023-8.
113. Public Health Nutr. 2006 Dec;9(8A):1136-40.
114. Am J Prev Med. 2005 Nov;29(4):335-46.
115. J Am Diet Assoc. 2005 Mar;105(3):428-40.
116. Mini Rev Med Chem. 2004 Oct;4(8):859-71.
117. Nurs Stand. 2004 Aug 11-17;18(48):38-42.
118. Cleve Clin J Med. 2004 Mar;71(3):208-10, 212, 215-8 passim.
119. J Am Diet Assoc. 2005 Jul;105(7):1080-6.
120. Int J Mol Sci. 2010 Feb 2;11(2):458-79.
121. Arch Intern Med. 2000 Mar 27;160(6):837-42.
122. Metabolism. 2006 Mar;55(3):381-90.
123. Biochem Biophys Acta. 2004 Jun 1;1682(1-3):80-91.
124. Anal Chim Acta. 2007 Feb 5;583(2):402-10.
125. J Agric Food Chem. 2007 Sep 5;55(18):7609-14.
126. Lipids. 2001 Nov;36(11):1195-202.
127. Eur J Cancer. 2000 Jun;36(10):1235-47.
128. Eur J Nutr. 2007 Mar;46(2):70-8. .
129. Nutrition. 2005 Feb;21(2):131-6.
130. Drug News Perspect. 2008 Dec;21(10):552-61.
131. J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67.
132. Am J Cardiol. 2011 Sep 1;108(5):691-7.
133. Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2487-94.
134. Lipids Health Dis. 2004;3:25.
135. J Pharmacol Sci. 2011;116(2):150-62.
136. Clin Interv Aging. 2010 Apr 7;5:45-61.
137. NUTRAfoods. 2005;4(4):70-72.
138. Biol Pharm Bull. 2003 Sep;26(9):1283-8.
139. Life Sci. 2003 Jun 13;73(4):471-85.
140. Mol Pharmacol. 2006 Jun;69(6):1783-90.
141. Mapo Pain Clinic, Seoul. November 2001. Scigenic Co., Ltd. Unpublished study report obtained from manufacturer.
142. J Agric Food Chem. 2008 Nov 26;56(22):10582-93.
143. Nutr J. 2008 Jan 21;7:3.1-9
144. Curr Med Res Opin. 2008 May;24(5):1485-96.
145. Complement Ther Med. 2012 Jun;20(3):124-30
146. Int J Food Sci Nutr. 2009;60 Suppl 2:99-113.
147. J Nutr Sci Vitaminol [Tokyo]. 2003 Dec;49[6]:442-6.
148. Prostaglandins Leukot Essent Fatty Acids. 1998 Mar;58(3):185-91
149. J Agric Food Chem. 1981 Sep-Oct;29(5):1089-91.
150. J Biol Chem 1940;134:781-2.
151. Arch Biochem Biophys 1966;113:251-2.
152. Toxicol Lett 2001;123:169-177.
153. Altern Med Rev. 2003 Nov;8(4):438-41.
154. Osteoarthritis Cartilage. 2008 Nov;16(11):1277-88.
155. Osteoarthritis and Cartilage 2006;14:286-94.
156. BMC Complement Altern Med. 2011 Jun 27;11:50.
157. Clin Drug Invest 2004; 24:353-63.
158. Iran J Pharmacol Ther 2004;3:61-5.
159. Evid Based Complement Alternat Med. 2011;2011:528403.
160. Curr Aging Sci. 2008 Dec;1(3):182-91.
161. Chin J Physiol. 2001 Mar 31;44(1):1-11.
162. Am J Physiol Cell Physiol. 2009 Dec;297(6):C1520-32.
163. J Neurosci Res. 2008 Aug 1;86(10):2339-52.
164. J Biol Chem. 2005 Mar 25;280(12):11648-55.
165. Life Extension-sponsored study #1.
166. Phytother Res. 2004 Dec;18(12):957-62.
167. Chinese Traditional and Herbal Drugs. 1991;22, 251,268.
168. Planta Med. 2001 Jul;67(5):391-5.
169. Planta Med. 2000 Mar;66(2):110-3.
170. Biochem Pharmacol. 2008 Jan 15;75(2):503-13.
171. Biol Pharm Bull. 2003 Sep;26(9):1342-4
172. J Nat Prod. 2002 Feb;65(2):179-83.
173. Nutr Rev. 2004 Jan;62(1):18-27.
174. Fortschr Med. 1989 Feb 10;107(4): 71-2.
175. Indian J Pharm Sci. 2008 Jan;70(1):114-7.
176. J Int Med Res. 1990 Sep-Oct;18(5):379-88.
177. J Biomed Nanotechnol. 2010 Dec;6(6):667-74

Customer Testimonials

Life Extension 5-LOX Inhibitor with AprèsFlex 100 mg, 60 vege caps

S$41.10

Pre Order Form

We will keep you posted on stock status.

Write a review

Related Products

Life Extension Immune Protect with Paractin®, 30 vegetarian capsules (Expiry Jul 2018)

Life Extension Enhanced Berry Complete with Acai, 60 vege caps

Life Extension Eye Pressure Support with Mirtogenol®, 30 vege caps